Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.425
Peer-review started: October 23, 2023
First decision: November 21, 2023
Revised: November 25, 2023
Accepted: December 27, 2023
Article in press: December 27, 2023
Published online: January 16, 2024
Processing time: 80 Days and 4.9 Hours
Inflammatory myofibroblastic tumors (IMTs) are exceptionally rare neoplasms with intermediate malignant potential. Surgery is the accepted treatment option, aiming for complete resection with clear margins.
A 39-year-old woman presented with a growing solitary pulmonary nodule measuring 2.0 cm in the right upper lobe (RUL) of the lung. The patient under-went a RUL anterior segmentectomy using uniportal video-assisted thoracoscopy. A preliminary tissue diagnosis indicated malignancy; however, it was later revised to an IMTs. Due to the absence of a minor fissure between the right upper and middle lobes, an alternative resection approach was necessary. Therefore, we utilized indocyanine green injection to aid in delineating the intersegmental plane. Following an uneventful recovery, the patient was discharged on the third postoperative day. Thereafter, annual chest tomography scans were scheduled to monitor for potential local recurrence.
This case underscores the challenges in diagnosing and managing IMTs, showing the importance of accurate pathologic assessments and tailored surgical strategies.
Core Tip: Inflammatory myofibroblastic tumors are rare neoplasms with intermediate malignant potential. Accurate diagnosis and tailored surgical strategies are crucial for successful management. This case highlights the challenges in diagnosing and treating such tumors, emphasizing the importance of precise pathological assessment and individualized surgical approaches.